purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Plasma-derived Medicinal Products
1.2 Key Market Segments
1.2.1 Plasma-derived Medicinal Products Segment by Type
1.2.2 Plasma-derived Medicinal Products Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Plasma-derived Medicinal Products Market Overview
2.1 Global Market Overview
2.1.1 Global Plasma-derived Medicinal Products Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma-derived Medicinal Products Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Plasma-derived Medicinal Products Market Competitive Landscape
3.1 Global Plasma-derived Medicinal Products Sales by Manufacturers (2019-2024)
3.2 Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma-derived Medicinal Products Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma-derived Medicinal Products Sales Sites, Area Served, Product Type
3.6 Plasma-derived Medicinal Products Market Competitive Situation and Trends
3.6.1 Plasma-derived Medicinal Products Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma-derived Medicinal Products Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Plasma-derived Medicinal Products Industry Chain Analysis
4.1 Plasma-derived Medicinal Products Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Plasma-derived Medicinal Products Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Plasma-derived Medicinal Products Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma-derived Medicinal Products Sales Market Share by Type (2019-2024)
6.3 Global Plasma-derived Medicinal Products Market Size Market Share by Type (2019-2024)
6.4 Global Plasma-derived Medicinal Products Price by Type (2019-2024)
7 Plasma-derived Medicinal Products Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma-derived Medicinal Products Market Sales by Application (2019-2024)
7.3 Global Plasma-derived Medicinal Products Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2019-2024)
8 Plasma-derived Medicinal Products Market Segmentation by Region
8.1 Global Plasma-derived Medicinal Products Sales by Region
8.1.1 Global Plasma-derived Medicinal Products Sales by Region
8.1.2 Global Plasma-derived Medicinal Products Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma-derived Medicinal Products Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma-derived Medicinal Products Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma-derived Medicinal Products Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma-derived Medicinal Products Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma-derived Medicinal Products Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Takeda
9.1.1 Takeda Plasma-derived Medicinal Products Basic Information
9.1.2 Takeda Plasma-derived Medicinal Products Product Overview
9.1.3 Takeda Plasma-derived Medicinal Products Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma-derived Medicinal Products SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma-derived Medicinal Products Basic Information
9.2.2 CSL Plasma-derived Medicinal Products Product Overview
9.2.3 CSL Plasma-derived Medicinal Products Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma-derived Medicinal Products SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Plasma-derived Medicinal Products Basic Information
9.3.2 Grifols Plasma-derived Medicinal Products Product Overview
9.3.3 Grifols Plasma-derived Medicinal Products Product Market Performance
9.3.4 Grifols Plasma-derived Medicinal Products SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Plasma-derived Medicinal Products Basic Information
9.4.2 Octapharma Plasma-derived Medicinal Products Product Overview
9.4.3 Octapharma Plasma-derived Medicinal Products Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Plasma-derived Medicinal Products Basic Information
9.5.2 Kedrion Plasma-derived Medicinal Products Product Overview
9.5.3 Kedrion Plasma-derived Medicinal Products Product Market Performance
9.5.4 Kedrion Business Overview
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Plasma-derived Medicinal Products Basic Information
9.6.2 LFB Group Plasma-derived Medicinal Products Product Overview
9.6.3 LFB Group Plasma-derived Medicinal Products Product Market Performance
9.6.4 LFB Group Business Overview
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Plasma-derived Medicinal Products Basic Information
9.7.2 Biotest Plasma-derived Medicinal Products Product Overview
9.7.3 Biotest Plasma-derived Medicinal Products Product Market Performance
9.7.4 Biotest Business Overview
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Plasma-derived Medicinal Products Basic Information
9.8.2 BPL Plasma-derived Medicinal Products Product Overview
9.8.3 BPL Plasma-derived Medicinal Products Product Market Performance
9.8.4 BPL Business Overview
9.8.5 BPL Recent Developments
9.9 Shanghai RAAS
9.9.1 Shanghai RAAS Plasma-derived Medicinal Products Basic Information
9.9.2 Shanghai RAAS Plasma-derived Medicinal Products Product Overview
9.9.3 Shanghai RAAS Plasma-derived Medicinal Products Product Market Performance
9.9.4 Shanghai RAAS Business Overview
9.9.5 Shanghai RAAS Recent Developments
9.10 China Biologic Products
9.10.1 China Biologic Products Plasma-derived Medicinal Products Basic Information
9.10.2 China Biologic Products Plasma-derived Medicinal Products Product Overview
9.10.3 China Biologic Products Plasma-derived Medicinal Products Product Market Performance
9.10.4 China Biologic Products Business Overview
9.10.5 China Biologic Products Recent Developments
9.11 Hualan Biological Engineering Inc.
9.11.1 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Basic Information
9.11.2 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Overview
9.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Market Performance
9.11.4 Hualan Biological Engineering Inc. Business Overview
9.11.5 Hualan Biological Engineering Inc. Recent Developments
9.12 Beijing Tiantan Biological Products Corp
9.12.1 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Basic Information
9.12.2 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Overview
9.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Market Performance
9.12.4 Beijing Tiantan Biological Products Corp Business Overview
9.12.5 Beijing Tiantan Biological Products Corp Recent Developments
9.13 Pacific Shuanglin
9.13.1 Pacific Shuanglin Plasma-derived Medicinal Products Basic Information
9.13.2 Pacific Shuanglin Plasma-derived Medicinal Products Product Overview
9.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Product Market Performance
9.13.4 Pacific Shuanglin Business Overview
9.13.5 Pacific Shuanglin Recent Developments
9.14 Boya Bio-Pharmaceutical
9.14.1 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Basic Information
9.14.2 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Overview
9.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Market Performance
9.14.4 Boya Bio-Pharmaceutical Business Overview
9.14.5 Boya Bio-Pharmaceutical Recent Developments
9.15 Paisi Feike Biology Pharmacy Co., Ltd.
9.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Basic Information
9.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product Overview
9.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product Market Performance
9.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
9.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
9.16 Xinjiang Deyuan Bioengineering
9.16.1 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Basic Information
9.16.2 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Overview
9.16.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Market Performance
9.16.4 Xinjiang Deyuan Bioengineering Business Overview
9.16.5 Xinjiang Deyuan Bioengineering Recent Developments
9.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
9.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Basic Information
9.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product Overview
9.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product Market Performance
9.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
9.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
9.18 Shenzhen Weiguang
9.18.1 Shenzhen Weiguang Plasma-derived Medicinal Products Basic Information
9.18.2 Shenzhen Weiguang Plasma-derived Medicinal Products Product Overview
9.18.3 Shenzhen Weiguang Plasma-derived Medicinal Products Product Market Performance
9.18.4 Shenzhen Weiguang Business Overview
9.18.5 Shenzhen Weiguang Recent Developments
9.19 Shanxi Kangbao
9.19.1 Shanxi Kangbao Plasma-derived Medicinal Products Basic Information
9.19.2 Shanxi Kangbao Plasma-derived Medicinal Products Product Overview
9.19.3 Shanxi Kangbao Plasma-derived Medicinal Products Product Market Performance
9.19.4 Shanxi Kangbao Business Overview
9.19.5 Shanxi Kangbao Recent Developments
9.20 Nanyue Biopharming Corporation Ltd
9.20.1 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Basic Information
9.20.2 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Overview
9.20.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Market Performance
9.20.4 Nanyue Biopharming Corporation Ltd Business Overview
9.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
10 Plasma-derived Medicinal Products Market Forecast by Region
10.1 Global Plasma-derived Medicinal Products Market Size Forecast
10.2 Global Plasma-derived Medicinal Products Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma-derived Medicinal Products Market Size Forecast by Country
10.2.3 Asia Pacific Plasma-derived Medicinal Products Market Size Forecast by Region
10.2.4 South America Plasma-derived Medicinal Products Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma-derived Medicinal Products by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Plasma-derived Medicinal Products Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma-derived Medicinal Products by Type (2025-2030)
11.1.2 Global Plasma-derived Medicinal Products Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma-derived Medicinal Products by Type (2025-2030)
11.2 Global Plasma-derived Medicinal Products Market Forecast by Application (2025-2030)
11.2.1 Global Plasma-derived Medicinal Products Sales (Kilotons) Forecast by Application
11.2.2 Global Plasma-derived Medicinal Products Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings